International Journal of Stroke: Volume 17 Issue 5, June 2022

Notice how useless the flagship WSO journal is.  Obviously nothing here is for survivors. That's why it needs to be destroyed and run by survivors.

1. NOTHING  on solving the 5 causes of the neuronal cascade of death in the first days.

2. NOTHING on 100% recovery!

3. NOTHING on creating rehab protocols!

4. How  much more fucking useless can the WSO get?
   

Oops, I'm not playing by the polite rules of Dale Carnegie,  'How to Win Friends and Influence People'. 

Telling supposedly smart stroke medical persons they know nothing about stroke is a no-no even if it is true. 

Politeness will never solve anything in stroke. Yes, I'm a bomb thrower and proud of it. Someday a stroke 'leader' will try to ream me out for making them look bad by being truthful, I look forward to that day.

International Journal of Stroke: Volume 17 Issue 5, June 2022 

Table of Contents (PDF)

Editorial Board (PDF)

Editorial

The return of in-person stroke conferences, thrombectomy for basilar occlusion, and advances in intracerebral hemorrhage Hugh S Markus First Published May 28, 2022; pp. 485–486 Abstract

Reviews

Telehealth for rehabilitation and recovery after stroke: State of the evidence and future directions Coralie English, Maria Gabriella Ceravolo, Simone Dorsch, Avril Drummond, Dorcas BC Gandhi, Judith Halliday Green, Ben Schelfaut, Paul Verschure, Gerard Urimubenshi, Sean Savitz First Published January 5, 2022; pp. 487–493 Abstract Preview

Intensive blood pressure lowering with nicardipine and outcomes after intracerebral hemorrhage: An individual participant data systematic review Kazunori Toyoda, Sohei Yoshimura, Mayumi Fukuda-Doi, Adnan I Qureshi, Renee’ Hebert Martin, Yuko Y Palesch, Masafumi Ihara, Jose I Suarez, Yasushi Okada, Chung Y Hsu, Ryo Itabashi, Yongjun Wang, Hiroshi Yamagami, Thorsten Steiner, Nobuyuki Sakai, Byung-Woo Yoon, Manabu Inoue, Kazuo Minematsu, Haruko Yamamoto, Masatoshi Koga, the ATACH Trial Investigators and the SAMURAI Investigators First Published September 20, 2021; pp. 494–505 Abstract Preview

Therapeutic hypothermia for intracerebral hemorrhage: Systematic review and meta-analysis of the experimental and clinical literature Turner S Baker, John Durbin, Zachary Troiani, Luis Ascanio-Cortez, Rebecca Baron, Anthony Costa, Fred Rincon, Frederick Colbourne, Patrick Lyden, Stephan A Mayer, Christopher P Kellner First Published September 22, 2021; pp. 506–516 Abstract Preview

Research

Risk factors for delayed-onset dementia after stroke or transient ischemic attack—A five-year longitudinal cohort study Moamina Ismail, Vincent CT Mok, Adrian Wong, Lisa Au, Brian Yiu, Zhaolu Wang, Winnie CW Chu, Anne YY Chan, Florence SY Fan, Sze H Ma, Vincent Ip, Bonaventure Ip, Karen Ma, Howan Leung, Yannie OY Soo, Thomas WH Leung, Ho Ko, Alexander YL Lau, Bonnie YK Lam First Published July 2, 2021; pp. 517–525 Abstract Preview

Characteristics and prognosis of patients with embolic stroke of undetermined source in China Xiaomeng Yang, Jing Jing, Xia Meng, Zixiao Li, Yuesong Pan, Yong Jiang, Xianglong Xiang, Huan Liu, Yu Chen, Liping Liu, Xingquan Zhao, Yilong Wang, Hao Li, Yongjun Wang First Published July 2, 2021; pp. 526–535 Abstract Preview

Comparative effectiveness and safety of edoxaban versus warfarin in patients with atrial fibrillation: A nationwide cohort study Peter B Nielsen, Mette Søgaard, Martin Jensen, Anne G Ording, Gregory YH Lip First Published July 13, 2021; pp. 536–544 Abstract Preview

Prehemorrhage antiplatelet use in aneurysmal subarachnoid hemorrhage and impact on clinical outcome Martina Sebök, Isabel C Hostettler, Emanuela Keller, Ilari M Rautalin, Bert A Coert, William P Vandertop, René Post, Ali Sardeha, Maud A Tjerkstra, Luca Regli, Dagmar Verbaan, Menno R Germans First Published July 29, 2021; pp. 545–552 Abstract Preview

Factors influencing the use of different methods of consent in a randomized acute stroke trial: The Third International Stroke Trial (IST-3) Richard I Lindley, Ingrid Kane, Geoff Cohen, Peter AG Sandercock First Published August 10, 2021; pp. 553–558 Abstract Preview

Impact of stroke center certification on rt-PA thrombolysis after acute ischemic stroke in South China from 2015 to 2020 Yicong Chen, Jiaoxing Li, Chao Dang, Shuangquan Tan, Fubing Ouyang, Jianle Li, Jian Yu, Jinsheng Zeng, Yuhua Fan First Published July 20, 2021; pp. 559–565 Abstract Preview

Thrombolysis outcomes according to arterial characteristics of acute ischemic stroke by alteplase dose and blood pressure target Zien Zhou, Chao Xia, Grant Mair, Candice Delcourt, Sohei Yoshimura, Xiaosheng Liu, Zengai Chen, Alejandra Malavera, Cheryl Carcel, Xiaoying Chen, Xia Wang, Rustam Al-Shahi Salman, Thompson G Robinson, Richard I Lindley, John Chalmers, Joanna M Wardlaw, Mark W Parsons, Andrew M Demchuk, Craig S Anderson First Published June 24, 2021; pp. 566–575 Abstract Preview

What is the median volume of intracerebral hemorrhage and is it changing? David Robinson, Carson Van Sanford, Soo Young Kwon, Elisheva Coleman, Padmini Sekar, Ryan Murphy, Matthew L Flaherty, Stacie L Demel, Yasmin Aziz, Charles J Moomaw, Mary Haverbusch, Jane Khoury, Opeolu Adeoye, Kyle B Walsh, Joseph P Broderick, Daniel Woo First Published July 22, 2021; pp. 576–582 Abstract Preview

Protocol

Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial Jonathan G Best, Liz Arram, Norin Ahmed, Maryam Balogun, Kate Bennett, Ekaterina Bordea, Marta G Campos, Emilia Caverly, Marisa Chau, Hannah Cohen, Hakim-Moulay Dehbi, Caroline J Doré, Stefan T Engelter, Robert Fenner, Nick Freemantle, Rachael Hunter, Martin James, Gregory YH Lip, Macey L Murray, Bo Norrving, Nikola Sprigg, Roland Veltkamp, Iwona Zaczyk, David J Werring, the OPTIMAS investigators First Published January 12, 2022; pp. 583–589 Abstract Preview